Research Paper Volume 16, Issue 15 pp 11513—11534
S100A9, as a potential predictor of prognosis and immunotherapy response for GBM, promotes the malignant progression of GBM cells and migration of M2 macrophages
Figure 6. The relationship between S100A9 and the marker genes of the chemokine pathway, receptor pathway, and MHC pathway. (A–C) Differential expression of the marker genes between high- and low-expression groups of S100A9. (D–F) The correlation between S100A9 and the marker genes.